PNC Financial Services Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5
| Closed | – | – | 4929 |
|
|
2022
Q3 | $0 | Sell |
5
-1,405
| -100% | – | ﹤0.01% | 4706 |
|
|
2022
Q2 | $44K | Sell |
1,410
-518
| -27% | -$16.2K | ﹤0.01% | 3069 |
|
|
2022
Q1 | $66K | Sell |
1,928
-1,985
| -51% | -$68K | ﹤0.01% | 2957 |
|
|
2021
Q4 | $114K | Sell |
3,913
-447
| -10% | -$13K | ﹤0.01% | 2600 |
|
|
2021
Q3 | $111K | Buy |
4,360
+638
| +17% | +$16.2K | ﹤0.01% | 2585 |
|
|
2021
Q2 | $131K | Sell |
3,722
-454
| -11% | -$16K | ﹤0.01% | 2497 |
|
|
2021
Q1 | $170K | Sell |
4,176
-46
| -1% | -$1.87K | ﹤0.01% | 2268 |
|
|
2020
Q4 | $183K | Sell |
4,222
-2,330
| -36% | -$101K | ﹤0.01% | 2124 |
|
|
2020
Q3 | $362K | Sell |
6,552
-23
| -0.3% | -$1.27K | ﹤0.01% | 1556 |
|
|
2020
Q2 | $414K | Buy |
6,575
+693
| +12% | +$43.6K | ﹤0.01% | 1495 |
|
|
2020
Q1 | $300K | Buy |
5,882
+1,530
| +35% | +$78K | ﹤0.01% | 1578 |
|
|
2019
Q4 | $346K | Sell |
4,352
-454
| -9% | -$36.1K | ﹤0.01% | 1715 |
|
|
2019
Q3 | $233K | Buy |
4,806
+454
| +10% | +$22K | ﹤0.01% | 2051 |
|
|
2019
Q2 | $229K | Hold |
4,352
| – | – | ﹤0.01% | 2085 |
|
|
2019
Q1 | $230K | Hold |
4,352
| – | – | ﹤0.01% | 2065 |
|
|
2018
Q4 | $179K | Sell |
4,352
-1
| -0% | -$41 | ﹤0.01% | 2125 |
|
|
2018
Q3 | $165K | Buy |
4,353
+3,835
| +740% | +$145K | ﹤0.01% | 2294 |
|
|
2018
Q2 | $23K | Buy |
518
+202
| +64% | +$8.97K | ﹤0.01% | 3400 |
|
|
2018
Q1 | $15K | Buy |
316
+290
| +1,115% | +$13.8K | ﹤0.01% | 3562 |
|
|
2017
Q4 | $1K | Buy |
+26
| New | +$1K | ﹤0.01% | 4113 |
|